Blog
RSS FeedPosted by Michael Wonder on 01 May 2023
New Zealand Pharmaceutical Schedule - 1 May 2023
The May 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 26 Apr 2023
Time taken for PHARMAC funding decisions ‘too long’, says Medicines NZ
26 April 2023 - It takes the nation's drug-buying agency, PHARMAC, an average of 7.7 years to make funding decisions ...
Posted by Michael Wonder on 20 Apr 2023
PHARMAC announces new Deputy Medical Director Māori
19 April 2023 - PHARMAC has welcomed Dr Kiri Prentice (Ngāi Tūhoe and Ngāti Awa) to the newly established role ...
Posted by Michael Wonder on 11 Apr 2023
PHARMAC funds second treatment for spinal muscular atrophy
11 April 2023 - PHARMAC has announced the funding of risdiplam (Evrysdi) for people with the rare genetic disorder spinal muscular ...
Posted by Michael Wonder on 05 Apr 2023
PHARMAC shares next steps in reviewing rule 8.1b
5 April 2023 - PHARMAC’s consultation on rule 8.1b of the Pharmaceutical Schedule has now closed. ...
Posted by Michael Wonder on 04 Apr 2023
PHARMAC seeking feedback on the COVID-19 anti-viral molnupiravir
4 April 2023 - PHARMAC are consulting on the role of molnupiravir in New Zealand’s portfolio of COVID-19 treatments. ...
Posted by Michael Wonder on 01 Apr 2023
New Zealand Pharmaceutical Schedule - 1 April 2023
1 April 2023 The April 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Mar 2023
Clarity around PHARMAC’s priority lists
30 March 2023 - PHARMAC released its first Clarity Report, containing the latest information about medicines, vaccines, and related products ...
Posted by Michael Wonder on 23 Mar 2023
PHARMAC considers funding rituximab for IgG4 related disease
23 March 2023 - PHARMAC has initiated a consultation today on widening funded access to rituximab (branded as Riximyo) for ...
Posted by Michael Wonder on 21 Mar 2023
Lobbying firms earning hundreds of thousands from contracts with Government agencies
20 March 2023 - The government drug buying agency PHARMAC made extensive use of Wellington firm Draper Cormack Group. ...
Posted by Michael Wonder on 20 Mar 2023
Indira Stewart on being called 'likely prejudiced' by PHARMAC
20 March 2023 - PHARMAC has today been “outed” for using a media-avoiding strategy, something many journalists have long suspected. ...
Posted by Michael Wonder on 12 Mar 2023
‘When’s our turn?’ PHARMAC's new funding won't cover breast cancer fighter's $100k bill
13 March 2023 - Hayley Steele has a hefty price tag on her life, one worth almost $100,000. ...
Posted by Michael Wonder on 07 Mar 2023
PHARMAC funds two new treatments for lung cancer
7 March 2023 - PHARMAC has announced the funding of two new medicines - pembrolizumab (Keytruda) and atezolizumab (Tecentriq) for people ...
Posted by Michael Wonder on 07 Mar 2023
PHARMAC announces decision to fund Trikafta
7 March 2023 - Pharmac has today confirmed the funding of elexacaftor with tezacaftor and ivacaftor (Trikafta) for people with cystic ...
Posted by Michael Wonder on 05 Mar 2023
Our progress in the funding of medicines for rare disorders
3 March 2023 - PHARMAC will hear from people affected by rare disorders in its upcoming Rare Disorders Advisory Committee meeting ...